Diffuse Follicle Center Lymphoma (DFCL) is a type of non-Hodgkin's lymphoma that originates in the lymphatic system. It is a rare but significant form of cancer that affects the lymph nodes of the head, face, and neck. DFCL is characterized by the uncontrolled growth of B-cells, which are a type of white blood cell that plays an essential role in the immune system.
Although the exact cause of DFCL is not yet known, certain risk factors such as age, exposure to radiation, and infection with certain viruses may increase the likelihood of developing the disease. Symptoms of DFCL may include painless swelling of the lymph nodes, fatigue, fever, night sweats, and weight loss.
The diagnosis of DFCL typically involves a biopsy of the affected lymph node, which is then examined under a microscope to determine the type and extent of the cancer. Imaging tests such as CT scans, PET scans, and MRI may also be used to help diagnose and stage the disease.
Treatment for DFCL typically involves a combination of chemotherapy, radiation therapy, and possibly immunotherapy. The specific treatment plan will depend on the stage and extent of the cancer, as well as the individual's overall health and medical history.
In conclusion, diffuse follicle center lymphoma is a rare but significant form of cancer that affects the lymph nodes of the head, face, and neck. Although the exact cause is unknown, certain risk factors may increase the likelihood of developing the disease. If you experience symptoms associated with DFCL, it is essential to seek medical attention promptly for an accurate diagnosis and treatment plan.
To see full information about treatment please Sign up or Log in